TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32996171

Group type: EXPERIMENTAL
Intervention: Increased education
Number of subjects: 26431

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure
Number of subjects: 26431

Group type: EXPERIMENTAL
Intervention: Total cholesterol
Number of subjects: 26431

Group type: EXPERIMENTAL
Intervention: LDL cholesterol
Number of subjects: 26431

Group type: EXPERIMENTAL
Intervention: Smoking initiation
Number of subjects: 26431

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 26431

Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 26431

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure and pulse pressure
Number of subjects: 26431
Study: 32639057

Group type: EXPERIMENTAL
Intervention: Royal Jelly 100 mg kg‐1 BW‐1 (RJ100)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Royal Jelly 200 mg kg‐1 BW‐1 (RJ200)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (RJ0)
Number of subjects: 25
Study: 34029321

Group type: EXPERIMENTAL
Intervention: FIFA 11+ soccer specific warm-up programme
Number of subjects: 626

Group type: COMPARATOR
Intervention: Usual warm up exercises
Number of subjects: 626
Study: 32658394

Group type: EXPERIMENTAL
Intervention: Posterior Release (PR)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Posteromedial Release (PMR)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Nonoperative correction
Number of subjects: 125
Study: 36273521

Group type: EXPERIMENTAL
Intervention: Telemedicine initial consultation
Number of subjects: 476

Group type: COMPARATOR
Intervention: Office visit initial consultation
Number of subjects: 476
Study: 34170884

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane blocks (n=29)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral blocks (n=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: General anaesthesia alone (n=30)
Number of subjects: 90
Study: 32129161

Group type: EXPERIMENTAL
Intervention: Darunavir-ritonavir (DRV/r) plus rilpivirine (RPV) once daily (QD)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Ongoing triple therapy
Number of subjects: 41
Study: 33832537

Group type: EXPERIMENTAL
Intervention: FASTER (Freiburger Asperger‐Spezifische Therapie für ERwachsene)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: SCOTT&EVA (Social Cognition Training Tool)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 360
Study: 32328036

Group type: EXPERIMENTAL
Intervention: Optimized group (γ IU/kg)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional group (0.15 IU/kg)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Optimized group (0.23 IU/kg)
Number of subjects: 140
Study: 34034262

Group type: EXPERIMENTAL
Intervention: Glucose loading
Number of subjects: 20
Study: 34907523

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multiple-injection costotransverse block (MICB) with three injections of 10 ml of ropivacaine (5 mg/ml)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo with three injections of 10 ml of saline (0.9%)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multiple-injection costotransverse block (MICB)
Number of subjects: 36
Study: 33487505

Group type: EXPERIMENTAL
Intervention: Self-reported coffee intake (more than 6 cups/day)
Number of subjects: 362571

Group type: EXPERIMENTAL
Intervention: Genetically instrumented coffee intake (one cup higher)
Number of subjects: 362571
Study: 32957332

Group type: EXPERIMENTAL
Intervention: Shexiang Tongxin dropping pill (STDP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no STDP)
Number of subjects: 64
Study: 33393630

Group type: EXPERIMENTAL
Intervention: 3 g fish oil/day (1.1 g eicosapentaenoic acid (EPA) + 0.8 g DHA)
Number of subjects: 2

Group type: COMPARATOR
Intervention: 3 g corn oil/day (placebo)
Number of subjects: 2
Study: 32850414

Group type: COMPARATOR
Intervention: IMRT alone (RT group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: IMRT combined with concurrent cisplatin (CCRT group)
Number of subjects: 84
Study: 35799195

Group type: EXPERIMENTAL
Intervention: Laser surgery (group A)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Electrosurgery (group B)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine surgery (group C)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Laser surgery (group A), Electrosurgery (group B), Routine surgery (group C)
Number of subjects: 63
Study: 33971912

Group type: EXPERIMENTAL
Intervention: Robot-aided somatosensory training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (non-stroke adults)
Number of subjects: 12
Study: 32652092

Group type: EXPERIMENTAL
Intervention: Lidocaine 10% spray
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%) spray
Number of subjects: 134
Study: 35778281

Group type: EXPERIMENTAL
Intervention: PVRV‐NG
Number of subjects: 0

Group type: COMPARATOR
Intervention: HDCV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVRV‐NG and HDCV (booster group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVRV‐NG and HDCV
Number of subjects: 0
Study: 34826225

Group type: EXPERIMENTAL
Intervention: Ritlecitinib (oral JAK3-selective inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33405253

Group type: EXPERIMENTAL
Intervention: Modified uvulopalatopharyngoplasty (UPPP)
Number of subjects: 65
Study: 32340927

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32024676

Group type: EXPERIMENTAL
Intervention: iPACK1
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: iPACK2
Number of subjects: 105

Group type: COMPARATOR
Intervention: TNB
Number of subjects: 105
Study: 33965757

Group type: EXPERIMENTAL
Intervention: Nonlinear pedagogy (NLP)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Differential learning (DL)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Linear pedagogy (LP)
Number of subjects: 66
Study: 32721994

Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Pre- and postprandial levels of insulin, leptin, glucose, and ghrelin
Number of subjects: 75
Study: 35488024

Group type: EXPERIMENTAL
Intervention: Brazil nut group (n = 29)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (n = 26)
Number of subjects: 55
Study: 32928601

Group type: EXPERIMENTAL
Intervention: Developmental intervention for youths with T1D and their parents
Number of subjects: 0
Study: 32663379

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg
Number of subjects: 273

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study: 35297715

Group type: EXPERIMENTAL
Intervention: Intermittent Walking (IW) - alternating 30 s treadmill walking and 30 s seated rests
Number of subjects: 18

Group type: COMPARATOR
Intervention: Continuous Walking (CW) - treadmill walking without breaks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intermittent Walking (IW)
Number of subjects: 18
Study: 33206192

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol, 2000 IU/d)
Number of subjects: 25871

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25871
Study: 35899436

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg b.i.d.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (b.i.d.)
Number of subjects: 12
Study: 33407413

Group type: EXPERIMENTAL
Intervention: Expressive arts-based intervention
Number of subjects: 154

Group type: COMPARATOR
Intervention: Treatment-as-usual waitlist control
Number of subjects: 154
Study: 33342331

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (individually modified education on diet, physical activity, and weight control)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Usual prenatal care (Control group)
Number of subjects: 281
Study: 35073354

Group type: EXPERIMENTAL
Intervention: Low burden of cerebral hypoxia (n=86)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: High burden of cerebral hypoxia (n=28)
Number of subjects: 166
Study: 33404656

Group type: EXPERIMENTAL
Intervention: Febuxostat (40 mg/day)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 36307360

Group type: EXPERIMENTAL
Intervention: STELAR intervention (multifaceted quality improvement program including educational outreach workshops, feedback of registry data, interprofessional education, barrier assessment, and action plan documentation)
Number of subjects: 3147

Group type: EXPERIMENTAL
Intervention: STELAR intervention
Number of subjects: 3147

Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 3147
Study: 34233229

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (running at moderate intensity for 30 min per day, 5 days a week for 12 weeks)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Psychoeducation (control group)
Number of subjects: 224
Study: 34213870

Group type: EXPERIMENTAL
Intervention: Ozone/oxygen injection (25 mu-g/mL in 20 mL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Methylprednisolone acetate (40mg) and lidocaine (40mg in 20 mL)
Number of subjects: 50
Study: 32086352

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35986684

Group type: EXPERIMENTAL
Intervention: Endoluminal stenting followed by elective surgery 1‐4 weeks later
Number of subjects: 245
Study: 33486426

Group type: EXPERIMENTAL
Intervention: Positive visual stimuli (happy emojis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative visual stimuli
Number of subjects: 0
Study: 35428276

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting NV-HAP
Number of subjects: 15420
Study: 32114572

Group type: EXPERIMENTAL
Intervention: Salivary retinol measurement using enzyme-linked immunosorbent assay
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plasma retinol measurement using high-performance liquid chromatography
Number of subjects: 30
Study: 33151474

Group type: EXPERIMENTAL
Intervention: Suprasegmental phonological training (12-week training on stress, intonation, and rhythm in English)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Suprasegmental phonological training
Number of subjects: 160
Study: 32109160

Group type: EXPERIMENTAL
Intervention: High-dose SVF
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low-dose SVF
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 36078566

Group type: EXPERIMENTAL
Intervention: Resistance Training (TR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Resistance Training with Pilates breathing (TR + P)
Number of subjects: 44
Study: 33691706

Group type: EXPERIMENTAL
Intervention: Indoor residual spraying (IRS) with pirimiphos-methyl (Actellic®300 CS)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: ITNs alone
Number of subjects: 20000
Study: 33156110

Group type: EXPERIMENTAL
Intervention: 3D models
Number of subjects: 116

Group type: COMPARATOR
Intervention: 2D images
Number of subjects: 116
Study: 85096255

Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (SAM)
Number of subjects: 0
Study: 34845913

Group type: EXPERIMENTAL
Intervention: Single-species mite allergen immunotherapy
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Double-species mite allergen immunotherapy
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 125
Study: 34480096

Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 230

Group type: COMPARATOR
Intervention: Anthracycline-containing regimens
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Standard treatment (anthracycline or taxane)
Number of subjects: 230
Study: 32270631

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) combined with conventional western medicine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional western medicine alone
Number of subjects: 49
Study: 35585937

Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET) plus Neurac method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Muscle Energy Technique (MET)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Neurac method
Number of subjects: 100
Study: 33754604

Group type: EXPERIMENTAL
Intervention: Intracorporeal injection (ICI)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intracorporeal injection (ICI) + phosphodiesterase inhibitor (PDE5i)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Phosphodiesterase inhibitor (PDE5i)
Number of subjects: 160
Study: 34658304

Group type: EXPERIMENTAL
Intervention: Designated-Video Group (DVG)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Free-Searching Group (FSG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Textbook Group (TG)
Number of subjects: 22
Study: 33766151

Group type: EXPERIMENTAL
Intervention: Active ABMT
Number of subjects: 145

Group type: COMPARATOR
Intervention: Sham ABMT
Number of subjects: 145

Group type: COMPARATOR
Intervention: Assessment-only
Number of subjects: 145
Study: 32091672

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham RIPC (control)
Number of subjects: 28
Study: 35220651

Group type: EXPERIMENTAL
Intervention: Serum CYFRA21‐1 levels
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Combination of MELD and CYFRA21‐1
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: CYFRA21‐1
Number of subjects: 824
Study: 32243651

Group type: COMPARATOR
Intervention: Ham F12 medium (Group A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 ng/mL recombinant basic fibroblast growth factor (bFGF) and 25 mg/500 mL 3′5′ cyclic adenosine monophosphate (cAMP) (Group B)
Number of subjects: 18
Study: 34861764

Group type: EXPERIMENTAL
Intervention: Presence of stuttering + low communication competence
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Absence of stuttering + low communication competence
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Presence of stuttering + high communication competence
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Absence of stuttering + high communication competence
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: High communication competence
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Low communication competence
Number of subjects: 158
Study: 33285699

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) enhancement during arthroscopic rotator cuff repair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard arthroscopic rotator cuff repair without PRP
Number of subjects: 0
Study: 35130374

Group type: EXPERIMENTAL
Intervention: M1 + S1 - tDCS (active stimulation for 20 min)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham tDCS (control stimulation for 20 min)
Number of subjects: 39
Study: 33248361

Group type: EXPERIMENTAL
Intervention: Increased physical activity (PA) through combined PA counselling and pedometer-based feedback
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 54
Study: 35998706

Group type: EXPERIMENTAL
Intervention: Multimodal telemonitoring
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual CPAP telemonitoring
Number of subjects: 168
Study: 32829594

Group type: EXPERIMENTAL
Intervention: Supine position group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lateral position group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hybrid position group
Number of subjects: 120
Study: 32621663

Group type: EXPERIMENTAL
Intervention: Topical triamcinolone acetonide 0.1% ointment twice daily for 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical tacrolimus 0.03% ointment twice daily for 2 weeks
Number of subjects: 50
Study: 34988847

Group type: EXPERIMENTAL
Intervention: Discontiguous (D-PVI) radiofrequency lesions
Number of subjects: 36

Group type: COMPARATOR
Intervention: Contiguous (C-PVI) radiofrequency lesions
Number of subjects: 36
Study: 33896627

Group type: COMPARATOR
Intervention: Canola meal (CM) inclusion at 0% crude protein from CM (CM0)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 15% crude protein from CM (CM15)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 30% crude protein from CM (CM30)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 45% crude protein from CM (CM45)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Canola meal (CM) inclusion at 60% crude protein from CM (CM60)
Number of subjects: 50
Study: 36128952

Group type: EXPERIMENTAL
Intervention: School-based interventions for obesity
Number of subjects: 25
Study: 34941914

Group type: EXPERIMENTAL
Intervention: Tigerase®
Number of subjects: 46

Group type: COMPARATOR
Intervention: Pulmozyme®
Number of subjects: 46
Study: 36184966

Group type: EXPERIMENTAL
Intervention: Park prescription (Park Rx) during routine clinical visits
Number of subjects: 500

Group type: COMPARATOR
Intervention: Care as usual (control arm)
Number of subjects: 500
Study: 33523583

Group type: EXPERIMENTAL
Intervention: Caregiver–oncologist prognostic concordance
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Caregiver–oncologist prognostic concordance among caregivers with low mastery
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Caregiver mastery
Number of subjects: 411

Group type: COMPARATOR
Intervention: Caregiver distress and quality of life (QoL) measures
Number of subjects: 411
Study: 36106673

Group type: EXPERIMENTAL
Intervention: Motor Skill Training (MST)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Strength and Flexibility Exercise (SFE)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Disability
Number of subjects: 83
Study: 33533285

Group type: EXPERIMENTAL
Intervention: Isotonic quadriceps muscle strength assessed with one-repetition maximum (1RM)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Isometric quadriceps muscle strength assessed with hand-held dynamometry (HHD)
Number of subjects: 89
Study: 32491082

Group type: EXPERIMENTAL
Intervention: Theory-based training to promote breast cancer screening (low worry intervention group)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Theory-based training to promote breast cancer screening (high worry control group)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Theory-based training to promote breast cancer screening (low worry intervention and high worry intervention)
Number of subjects: 285
Study: 34922649

Group type: EXPERIMENTAL
Intervention: Namilumab (150 mg, single intravenous dose)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg, single intravenous dose)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Namilumab
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 146
Study: 34507235

Group type: EXPERIMENTAL
Intervention: Endoscopic cartilage with perichondrium composite graft underlay technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endoscopic perichondrial graft overlay and cartilage underlay technique
Number of subjects: 80
Study: 32881710

Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY) for 30 min, 6 days/week for 8 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sitting activity and Suryanamaskar for 4 weeks each (Control)
Number of subjects: 52
Study: 36370460

Group type: EXPERIMENTAL
Intervention: Bubble CPAP (5-8 cm H2O)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Bubble NIPPV (Phigh 8-10 cm H2O/Plow 5-8 cm H2O)
Number of subjects: 7
Study: 32333540

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham‐EA
Number of subjects: 104

Group type: COMPARATOR
Intervention: Epidural block
Number of subjects: 104
Study: 36066478

Group type: EXPERIMENTAL
Intervention: Bowel training and defecation posture intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: General care (control group)
Number of subjects: 30
Study: 35512824

Group type: EXPERIMENTAL
Intervention: Recurrent patella dislocation patients
Number of subjects: 148
Study: 33017169

Group type: EXPERIMENTAL
Intervention: HTT technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AM portal technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: TT technique
Number of subjects: 30
Study: 34780602

Group type: EXPERIMENTAL
Intervention: Postoperative mobilization (defined as the fraction of monitored time spent sitting or standing)
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Average pain score increase
Number of subjects: 673

Group type: COMPARATOR
Intervention: Postoperative complications
Number of subjects: 673
Study: 33473174

Group type: EXPERIMENTAL
Intervention: DXA measured VAT mass
Number of subjects: 1482

Group type: EXPERIMENTAL
Intervention: VAT mass cut-offs
Number of subjects: 1482

Group type: EXPERIMENTAL
Intervention: DXA measured VAT
Number of subjects: 1482
Study: 32491124

Group type: EXPERIMENTAL
Intervention: Dry bed bath
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional bed bath
Number of subjects: 15
Study: 35274093

Group type: EXPERIMENTAL
Intervention: CHARM2 intervention (five provider-delivered sessions on gender equity and family planning)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: CHARM2 intervention
Number of subjects: 1201

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1201
Study: 32558214

Group type: EXPERIMENTAL
Intervention: Home treatment (HoT) after 4–8 weeks of inpatient treatment, with visits by a multi-professional team 3-4 times per week for the first two months and 1-2 times per week for the third and fourth months.
Number of subjects: 22
Study: 32683645

Group type: EXPERIMENTAL
Intervention: 12 months of dual antiplatelet therapy (DAPT)
Number of subjects: 1399

Group type: COMPARATOR
Intervention: 30 months of dual antiplatelet therapy (DAPT)
Number of subjects: 1399
Study: 34664829

Group type: EXPERIMENTAL
Intervention: CT nano-contrast agent
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional iohexol contrast agent
Number of subjects: 100
Study: 34048083

Group type: EXPERIMENTAL
Intervention: High-intensity training (HIT) for 20 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: High-intensity training (HIT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: High-intensity training (HIT) and Standard care (control)
Number of subjects: 39